Teams from the WVU Cancer Institute and the WVU Heart and Vascular Institute (HVI) successfully introduced a groundbreaking thoracic oncology treatment using pulse electric field (PEF) ablation ...

SIL204 Demonstrated Significant Tumor Inhibition in Positive Pre Clinical Studies with Activity Across Pancreatic, Colorectal, and Lung Cancer ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Bayer received significant designations in the U.S. and China for its sevabertinib lung-cancer treatment.

Ceralasertib is an oral selective inhibitor of the ATR kinase, an important DNA-repairing protein in tumor cells.

Multidimensional intervention for patients with lung cancer incorporates rehabilitation, psychosocial support, nutrition guidance, health promotion, and safety surveillance. Multidimensional ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed ...